Diagnostic and treatment of fibrinothorax

Author:

Lishenko V. V.1ORCID,Zaytsev D. A.2ORCID,Kochetkov A. V.2ORCID,Kurygin A. A.1ORCID

Affiliation:

1. Military Medical Academy

2. A. M. Nikiforov Russian Center of Emergency and Radiation Medicine

Abstract

The OBJECTIVE was to promote the official introduction into clinical practice of the term «fibrinothorax» as a separate nosological unit and a special form of exudative pleurisy. This term reflects the essence and timing of the pathological process in the pleural cavity and defines a specific set of necessary therapeutic and diagnostic measures.METHODS AND MATHERIALS. 67 patients with fibrinothorax of different volumes were examined and treated. Two methods of pleural cavity sanitation were used: operative (thoracoscopic) and «closed» with the use of proteolytic enzymes.RESULTS. Among 67 patients, the leading cause of fibrinothorax was nonspecific (para- and metapneumonic) pleurisy – 48 (72 %) patients. In 7 (10 %) cases, fibrinothorax was established, which complicated the course of pleurisy of tuberculous etiology. In 6 (9 %) cases, pleural effusion was a transudate, in which, against the background of repeated punctures and long periods of fluid accumulation in the pleural cavity, partial delineations in the form of fibrinothorax formed. Carcinomatous pleurisy was diagnosed in 6 (9 %) patients of the study group. Pleural cavity sanitation through the use of proteolytic enzymes was performed in 49 (73 %) of 67 patients. Thoracoscopic sanitation with biopsy for fibrinothorax was performed in 18 (27 %) patients. This material formed the basis of the concept of diagnosis of fibrinothorax and optimization of treatment.CONCLUSION. The introduction of the term «fibrinothorax» into clinical practice, reflecting the essence of this pathological condition, contributes to the formation of a treatment and diagnostic algorithm aimed at the sanitation of the pleural cavity in optimal ways.

Publisher

FSBEI HE I.P. Pavlov SPbSMU MOH Russia

Subject

General Medicine

Reference13 articles.

1. A large medical encyclopedia. Vol. 10 / eds by B. V. Petrovsky. Moscow, 1979:1553–1556. (In Russ.).

2. Kotiv B. N., Barinov O. V., Bashilov N. I. The role of scientists of the Military Medical Academy named after S. M. Kirov in the study of the problem of treatment of purulent-destructive diseases of the lungs and pleura // Bulletin of the Russian Military Medical Academy. 2015;1(49):189–193. (In Russ.).

3. Lishenko V. V., Zaitsev D. A. Therapeutic tactics in fibrinothorax // Pulmonology. 2010;(4):54–57. (In Russ.).

4. Zaitsev D. A., Movchan K. N., Lishenko V. V. Possibilities of modern technologies of examination and treatment of patients with fibrinothorax // International Journal of Applied and Fundamental Research. 2015;(6–3):436–439. (In Russ.)

5. Now I. V., Moskvichev B. V., Ivanova G. P. Nanobiotechnological form of therapeutic proteolytic enzyme terrilitin – terridecase // Polyclinic. 2011; (2–1):93–95. (In Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3